Japan· JP-3999453G2028
ダルベポエチンアルファ（遺伝子組換え）［ダルベポエチンアルファ後続１］
A medicinal product containing ダルベポエチンアルファ（遺伝子組換え）［ダルベポエチンアルファ後続１］, registered in Japan by ＪＣＲファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ダルベポエチンアルファ（遺伝子組換え）［ダルベポエチンアルファ後続１］
- Manufacturer
- ＪＣＲファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ダルベポエチンアルファ（遺伝子組換え）［ダルベポエチンアルファ後続１］ in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARANESPAmgen Europe B.V., Breda
- FinlandAranespAmgen Europe B.V.
- SpainARANESP 10 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADAAmgen Europe B.V.
- IcelandAranespAmgen Europe B.V.*
- SwedenAranesp 10 mikrogram Injektionsvätska, lösning i förfylld injektionspennaAmgen Europe B.V.
- BelgiumAranesp 10 µg/0.4 mlAmgen Europe
- NetherlandsAranesp 10 microgram, oplossing voor injectie in een voorgevulde pen (SureClick)Amgen Europe B.V.
- United StatesARANESPAmgen, Inc
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Aranesp
- Norway · Aranesp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7f5ffba-29f9-4313-88fd-baad4d88198a GET /v1/drugs/e7f5ffba-29f9-4313-88fd-baad4d88198a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０μｇ０．５ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999453G2028",
"category": "注射薬",
"price_yen": 688,
"generic_name": "ダルベポエチンアルファ（遺伝子組換え）［ダルベポエチンアルファ後続１］",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about ダルベポエチンアルファ（遺伝子組換え）［ダルベポエチンアルファ後続１］.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.